Wall Street analysts expect CME Group Inc (NASDAQ:CME) to report sales of $1.26 billion for the current fiscal quarter, Zacks reports. Four analysts have made estimates for CME Group’s earnings, with estimates ranging from $1.19 billion to $1.31 billion. CME Group posted sales of $1.06 billion during the same quarter last year, which would indicate a positive year over year growth rate of 18.9%. The company is scheduled to report its next earnings report before the market opens on Wednesday, July 31st.

On average, analysts expect that CME Group will report full year sales of $4.87 billion for the current fiscal year, with estimates ranging from $4.73 billion to $4.98 billion. For the next financial year, analysts anticipate that the firm will post sales of $5.13 billion, with estimates ranging from $4.98 billion to $5.32 billion. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side analysts that follow CME Group.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, May 1st. The financial services provider reported $1.62 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.60 by $0.02. The business had revenue of $1.18 billion for the quarter, compared to analysts’ expectations of $1.19 billion. CME Group had a return on equity of 9.29% and a net margin of 42.47%. The business’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.86 EPS.

Several research analysts have recently weighed in on the company. BidaskClub upgraded CME Group from a “sell” rating to a “hold” rating in a report on Thursday, April 18th. Zacks Investment Research upgraded CME Group from a “sell” rating to a “hold” rating in a research note on Wednesday, April 17th. ValuEngine cut CME Group from a “buy” rating to a “hold” rating in a research note on Wednesday, March 20th. Finally, UBS Group decreased their price target on CME Group from $179.00 to $175.00 and set a “neutral” rating on the stock in a research note on Thursday, May 2nd. Three equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and eight have given a buy rating to the stock. CME Group has a consensus rating of “Hold” and a consensus price target of $192.14.

In related news, Director Charles P. Carey sold 10,000 shares of the stock in a transaction that occurred on Wednesday, May 8th. The shares were sold at an average price of $179.02, for a total transaction of $1,790,200.00. Following the completion of the sale, the director now directly owns 37,799 shares of the company’s stock, valued at $6,766,776.98. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Timothy S. Bitsberger sold 700 shares of the stock in a transaction that occurred on Tuesday, June 4th. The shares were sold at an average price of $194.35, for a total transaction of $136,045.00. Following the sale, the director now directly owns 9,421 shares of the company’s stock, valued at $1,830,971.35. The disclosure for this sale can be found here. Insiders have sold a total of 46,373 shares of company stock worth $8,964,499 in the last ninety days. 1.20% of the stock is currently owned by insiders.

A number of institutional investors have recently added to or reduced their stakes in the business. Dubuque Bank & Trust Co. boosted its position in shares of CME Group by 83.1% in the first quarter. Dubuque Bank & Trust Co. now owns 152 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 69 shares during the period. Resources Investment Advisors Inc. raised its stake in CME Group by 2,800.0% during the fourth quarter. Resources Investment Advisors Inc. now owns 145 shares of the financial services provider’s stock worth $27,000 after acquiring an additional 140 shares in the last quarter. Truvestments Capital LLC acquired a new position in CME Group during the first quarter worth about $32,000. Close Asset Management Ltd acquired a new position in shares of CME Group in the first quarter valued at approximately $34,000. Finally, Capital Financial Planning LLC bought a new stake in CME Group in the fourth quarter valued at approximately $40,000. Hedge funds and other institutional investors own 84.67% of the company’s stock.

Shares of CME Group stock traded up $1.18 on Wednesday, hitting $203.17. 989,076 shares of the company were exchanged, compared to its average volume of 1,673,825. The stock has a market cap of $72.40 billion, a PE ratio of 29.70, a price-to-earnings-growth ratio of 4.59 and a beta of 0.23. The stock’s 50-day moving average is $195.91. CME Group has a 1-year low of $158.35 and a 1-year high of $204.56. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.16.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 10th were issued a dividend of $0.75 per share. The ex-dividend date of this dividend was Friday, June 7th. This represents a $3.00 annualized dividend and a dividend yield of 1.48%. CME Group’s payout ratio is 43.99%.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

See Also: How is a price target determined?

Get a free copy of the Zacks research report on CME Group (CME)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.